These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8330389)

  • 1. In patients receiving dopamine infusions for treatment of shock do free radicals convert dopamine to 6-hydroxydopamine?
    Tong J; Baines AD
    Clin Biochem; 1993 Jun; 26(3):199-205. PubMed ID: 8330389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between 6-hydroxydopamine and transferrin: "Let my iron go".
    Borisenko GG; Kagan VE; Hsia CJ; Schor NF
    Biochemistry; 2000 Mar; 39(12):3392-400. PubMed ID: 10727233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of hydroxyl radical attack on dopa, dopamine, 6-hydroxydopa, and 6-hydroxydopamine.
    Nappi AJ; Vass E; Prota G; Memoli S
    Pigment Cell Res; 1995 Dec; 8(6):283-93. PubMed ID: 8789736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study.
    Ferger B; Teismann P; Mierau J
    Brain Res; 2000 Nov; 883(2):216-23. PubMed ID: 11074050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum.
    Opacka-Juffry J; Wilson AW; Blunt SB
    Brain Res; 1998 Nov; 810(1-2):27-33. PubMed ID: 9813228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
    Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
    Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice.
    Naudin B; Bonnet JJ; Costentin J
    Brain Res; 1995 Dec; 701(1-2):151-7. PubMed ID: 8925278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation.
    Dajas-Bailador FA; Martinez-Borges A; Costa G; Abin JA; Martignoni E; Nappi G; Dajas F
    Brain Res; 1998 Nov; 813(1):18-25. PubMed ID: 9824659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructure of Met5-enkephalin terminals in the caudate-putamen nuclei of adult rats receiving neonatal intranigral 6-hydroxydopamine.
    Pickel VM; Chan J; Pierce JP
    Brain Res Dev Brain Res; 1994 Dec; 83(2):163-80. PubMed ID: 7697877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants.
    Méndez-Alvarez E; Soto-Otero R; Hermida-Ameijeiras A; López-Martín ME; Labandeira-García JL
    Free Radic Biol Med; 2001 Oct; 31(8):986-98. PubMed ID: 11595383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of cysteinyl-dopamine during intravenous dopamine therapy.
    Magnay JL; Tong J; Drangova R; Baines AD
    Kidney Int; 2001 May; 59(5):1891-8. PubMed ID: 11318961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain.
    Asanuma M; Ogawa N; Nishibayashi S; Kawai M; Kondo Y; Iwata E
    Arch Int Pharmacodyn Ther; 1995; 329(2):221-30. PubMed ID: 8540762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.
    Borah A; Mohanakumar KP
    Brain Res; 2010 Jul; 1344():192-9. PubMed ID: 20470760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice.
    Varcin M; Bentea E; Mertens B; Haute CV; Baekelandt V; Michotte Y; Sarre S
    J Neurosci Methods; 2011 Nov; 202(2):128-36. PubMed ID: 21782850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
    Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation.
    Ferger B; Themann C; Rose S; Halliwell B; Jenner P
    J Neurochem; 2001 Aug; 78(3):509-14. PubMed ID: 11483653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release.
    Ganapathy K; Datta I; Sowmithra S; Joshi P; Bhonde R
    J Cell Biochem; 2016 Dec; 117(12):2719-2736. PubMed ID: 27064513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.